PTTG3P
Putative pituitary tumor-transforming gene 3 protein
Also known as: PTTG3_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for PTTG3P in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
202 residues, UniProt reviewed canonical sequence.
>Q9NZH4|PTTG3P
1 MATLIYVDKE NEEPGILVAT KDGLKLGSGP SIKALDGRSQ VSISCFGKTF DAPTSLPKAT
61 RKALGTVNRA TEKSVKTNGP LKQKQPSFSA KKMTEKTVKA KNSVPASDDG YPEIEKLFPF
121 NPLGFESFDL PEEHQIAHLP LSEVPLMILD EERELEKLFQ LGPPSPLKMP SPPWKSNLLQ
181 SPLSILLTLD VELPPVCSDI DILocalizationUniProt · AlphaFold · HPA
Whether an antibody against PTTG3P can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.69
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PTTG3P as an antibody target. Whether an autoantibody or antibody against PTTG3P could matter depends on whether native PTTG3P is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PTTG3P is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PTTG3P as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...